Screener
Vor Biopharma VOR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $1,043 | $5,127 |
| Accrued liabilities | 14,727 | 19,764 |
| Operating lease liabilities | 307 | 280 |
| Total current liabilities | 16,077 | 25,171 |
| Non-current liabilities: | ||
| Operating lease liabilities, less current portion | 2,632 | 2,720 |
| Warrant liabilities | 638,461 | 600,547 |
| Total liabilities | 657,170 | 628,438 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's total current liabilities?
- Vor Biopharma (VOR) reported total current liabilities of $16.08M in Q1 2026.
- How has Vor Biopharma's total current liabilities changed year-over-year?
- Vor Biopharma's total current liabilities decreased by 3.9% year-over-year, from $16.73M to $16.08M.
- What is the long-term trend for Vor Biopharma's total current liabilities?
- Over 5 years (2020 to 2025), Vor Biopharma's total current liabilities has grown at a 19.8% compound annual growth rate (CAGR), from $10.21M to $25.17M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Vor Biopharma's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude